A prospective, multicenter analysis of the integrated 31-gene expression profile test for sentinel lymph node biopsy (i31-GEP for SLNB) test demonstrates reduced number of unnecessary SLNBs in patients with cutaneous melanoma

A prospective, multicenter analysis of the integrated 31-gene expression profile test for sentinel lymph node biopsy (i31-GEP for SLNB) test demonstrates reduced number of unnecessary SLNBs in patients with cutaneous melanoma

National Comprehensive Cancer Network guidelines recommend sentinel lymph node biopsy (SLNB) for patients with > 10% risk of positivity, consider SLNB with 5-10% risk, and foregoing with

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of surgical oncology 2025-01, Vol.23 (1), p.5
Hauptverfasser: Guenther, J Michael, Ward, Andrew, Martin, Brian J, Cripe, Mark, Sharma, Rohit, Leong, Stanley P, Clark, Joseph I, Hamner, John, Beard, Timothy
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:National Comprehensive Cancer Network guidelines recommend sentinel lymph node biopsy (SLNB) for patients with > 10% risk of positivity, consider SLNB with 5-10% risk, and foregoing with
ISSN:1477-7819
1477-7819
DOI:10.1186/s12957-024-03640-x